Detailing one of Europe’s largest human- and animal-based research material portfolios

Sera Laboratories International Ltd (Sera Lab), the serum specialist, has launched a new BioProducts catalogue presenting its extensive range of animal and human material, disease state material and the new range of Human Tissues.

Animal control material is collected from colonies of drug naïve animals under veterinary supervision. Human control material is collected from FDA registered facilities and is fully viral tested to current FDA regulations.

Sera Lab retains a comprehensive inventory of disease state material sourced from clinical diagnostic laboratories as remnant specimens. Samples may also be collected prospectively using existing IRB permits. Human Tissues are collected at registered facilities in the US from both normal and disease state donors and are shipped directly to the end user.

The newly available BioProducts catalogue from Sera Lab gives details of one of Europe’s largest ranges of biological products for use in life science research and drug discovery applications. To ensure rapid delivery times, a comprehensive inventory of more frequently requested samples listed within the catalogue is retained, whilst more esoteric material is collected to order by Sera Lab.

To request a catalogue or for more information, email sales@seralab.co.uk or visit www.seralab.co.uk

About Sera Lab

Founded in 1998, Sera Laboratories International Ltd (Sera Lab), the serum specialist, is a leading supplier of core biomedical products and services for clinical and research diagnostics, drug discovery and development, and life science research. With headquarters and storage in the UK and a cell culture research facility in France, Sera Lab offers the most complete range of animal-based research products in Europe from a wide variety of origins. Sera Lab supplies laboratories in over 30 countries throughout the world, either directly or through distributors. A new UK production facility at a sister company has further expanded the company’s capabilities and capacity.

Sera Lab’s quality products provide key advantages in a range of research disciplines including cell biology, genomics, proteomics, virology, immunology, drug discovery and toxicology. They are important tools for defining the pharmacokinetic and pharmacodynamic properties of newly discovered compounds and their effects on disease processes. With over 30 years experience, the company’s management and R&D teams are continually developing new products that allow researchers to push the boundaries of research. Through an exclusive association with UK-based Antibody Production Services Limited (APS), Sera Lab offers a Custom Antibody Service to provide polyclonal and monoclonal antibodies from a wide variety of species.

Sera Lab’s Contract Manufacture Service can supply any serum, plasma or media product to suit a customer’s individual requirements. Other contract services include filtration, media production and freeze-drying.